IRIS
FILIPPI, ANDREA RICCARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.277
AS - Asia 1.402
EU - Europa 1.182
SA - Sud America 207
AF - Africa 24
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 3
Totale 5.100
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.212
IE - Irlanda 554
SG - Singapore 515
CN - Cina 418
HK - Hong Kong 280
RU - Federazione Russa 200
BR - Brasile 171
DE - Germania 104
VN - Vietnam 82
IT - Italia 79
FI - Finlandia 71
CA - Canada 44
GB - Regno Unito 34
IN - India 34
SE - Svezia 31
CZ - Repubblica Ceca 28
JP - Giappone 15
MX - Messico 15
FR - Francia 14
AR - Argentina 13
BD - Bangladesh 11
BE - Belgio 11
NL - Olanda 11
IQ - Iraq 10
TR - Turchia 10
ZA - Sudafrica 10
AT - Austria 9
PL - Polonia 9
CO - Colombia 6
LT - Lituania 6
MA - Marocco 6
SA - Arabia Saudita 5
CL - Cile 4
UA - Ucraina 4
AE - Emirati Arabi Uniti 3
EC - Ecuador 3
ES - Italia 3
EU - Europa 3
KE - Kenya 3
PK - Pakistan 3
PY - Paraguay 3
VE - Venezuela 3
AU - Australia 2
AZ - Azerbaigian 2
BO - Bolivia 2
BY - Bielorussia 2
CH - Svizzera 2
EE - Estonia 2
GR - Grecia 2
HN - Honduras 2
ID - Indonesia 2
JO - Giordania 2
KG - Kirghizistan 2
PA - Panama 2
PT - Portogallo 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
BH - Bahrain 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
GM - Gambi 1
HU - Ungheria 1
IS - Islanda 1
JM - Giamaica 1
KR - Corea 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MM - Myanmar 1
MU - Mauritius 1
NC - Nuova Caledonia 1
PE - Perù 1
TZ - Tanzania 1
UY - Uruguay 1
UZ - Uzbekistan 1
YE - Yemen 1
Totale 5.100
Salva come PNG Salva come JPEG
Città #
Dublin 553
Ashburn 340
Chandler 334
Hong Kong 276
Singapore 194
Dallas 166
Beijing 142
Boardman 119
Princeton 116
Lawrence 98
Medford 80
Los Angeles 64
Wilmington 64
Shanghai 63
Washington 49
Helsinki 45
Munich 44
Redondo Beach 44
Buffalo 42
New York 33
Ho Chi Minh City 27
Moscow 25
Turku 25
Toronto 23
Brno 22
Pavia 22
Norwalk 18
São Paulo 18
Nuremberg 17
Ann Arbor 16
Chicago 15
Hanoi 15
Stockholm 15
London 14
Milan 14
Tokyo 14
The Dalles 13
Brussels 11
Council Bluffs 11
Columbus 10
Falkenstein 10
Guangzhou 10
Saint Louis 10
Santa Clara 10
Chennai 9
Düsseldorf 8
Phoenix 8
Ankara 7
Boston 7
Denver 7
Mexico City 7
Montreal 7
Orem 7
Seattle 7
Zhengzhou 7
Frankfurt am Main 6
Johannesburg 6
New Delhi 6
Redwood City 6
Rio de Janeiro 6
San Jose 6
Vienna 6
Amsterdam 5
Brooklyn 5
Canyon Country 5
Houston 5
Olomouc 5
Warsaw 5
Belo Horizonte 4
Changsha 4
Curitiba 4
Dong Ket 4
Shenzhen 4
Tianjin 4
Anyang 3
Asunción 3
Atlanta 3
Baghdad 3
Calgary 3
Charlotte 3
Chengdu 3
Dhaka 3
Goiânia 3
Hangzhou 3
Liaocheng 3
Maceió 3
Malo 3
Manchester 3
Nairobi 3
Ottawa 3
Pelotas 3
Poplar 3
Portsmouth 3
Pune 3
Riyadh 3
San Francisco 3
Taiyuan 3
Thái Bình 3
Torino 3
Vancouver 3
Totale 3.506
Salva come PNG Salva come JPEG
Nome #
Integrating data from multidisciplinary Management of Malignant Pleural Mesothelioma: a cohort study 98
The efficacy of immunonutrition in improving tolerance to chemoradiotherapy in patients with head and neck cancer, receiving nutritional counseling: study protocol of a randomized, open-label, parallel group, bicentric pilot study 95
Recent advancement on PD-L1 expression quantification: the radiologist perspective on CT-guided FNAC 81
Management of the axilla in patients with breast cancer and positive sentinel lymph node biopsy: An evidence-based update in a European breast center 80
Combination of novel systemic agents and radiotherapy for solid tumors – part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy 78
Integrating data from multidisciplinary Management of Malignant Pleural Mesothelioma: a cohort study 77
Correlation between PD-L1 Expression of Non-Small Cell Lung Cancer and Data from IVIM-DWI Acquired during Magnetic Resonance of the Thorax: Preliminary Results 77
The growth of non-solid neoplastic lung nodules is associated with low PD L1 expression, irrespective of sampling technique 76
Malignant pleural mesothelioma: Genetic and microenviromental heterogeneity as an unexpected reading frame and therapeutic challenge 76
Immunonutrition in head and neck cancer patients undergoing chemoradiotherapy: An alternative approach for overcoming potential bias 75
Combination of novel systemic agents and radiotherapy for solid tumors – Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity 73
COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy 72
A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer 71
Non-invasive PD-L1 stratification in non-small cell lung cancer using dynamic contrast-enhanced MRI 70
Whey protein isolate supplementation improves body composition, muscle strength, and treatment tolerance in malnourished advanced cancer patients undergoing chemotherapy 69
Back to (new) normality—A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 2 69
Local Therapies and Modulation of Tumor Surrounding Stroma in Malignant Pleural Mesothelioma: A Translational Approach 66
Salvage Treatment and Survival for Relapsed Follicular Lymphoma Following Primary Radiation Therapy: A Collaborative Study on Behalf of ILROG 66
Addition of rituximab to involved-field radiation therapy prolongs progression-free survival in stage I-II follicular lymphoma: Results of a multicenter study 66
Changes in breast cancer risk associated with different volumes, doses, and techniques in female Hodgkin's lymphoma patients treated with supra-diaphragmatic radiation therapy 66
To a new normal in radiation oncology: looking back and planning forward 66
The prognostic impact of BIA-derived fat-free mass index in patients with cancer 66
Oligometastasis and local ablation in the era of systemic targeted and immunotherapy 65
Comparison of Gafchromic EBT2 and EBT3 for patient-specific quality assurance: Cranial stereotactic radiosurgery using volumetric modulated arc therapy with multiple noncoplanar arcs 63
COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 63
COVID-19 OUTBREAK IN NORTHERN ITALY: FIRST PRACTICAL INDICATIONS FOR RADIOTHERAPY DEPARTMENTS 61
Clinical applications of stereotactic radiation therapy for oligometastatic cancer patients: a disease-oriented approach 58
COVID-19 safe and fully operational radiotherapy: An AIRO survey depicting the Italian landscape at the dawn of phase 2 57
Definitive radiotherapy for localized follicular lymphoma staged by18F-FDG PET-CT: A collaborative study by ILROG 56
Fondazione Italiana Linfomi (FIL) expert consensus on the use of intensity-modulated and image-guided radiotherapy for Hodgkin's lymphoma involving the mediastinum 56
Radiomics features as predictive and prognostic biomarkers in NSCLC 56
Pulmonary function and quality of life after VMAT-based stereotactic ablative radiotherapy for early stage inoperable NSCLC: A prospective study 55
Postoperative Radiotherapy for Patients With Completely Resected Pathologic N2 Non-Small-Cell Lung Cancer: A Retrospective Analysis 54
COVID-19: Global radiation oncology's targeted response for pandemic preparedness 54
Intrathoracic core needle biopsy and repeat biopsy for PD-L1 evaluation in non-small cell lung cancer 53
Alternative options for elderly patients with limited stage diffuse large B-cell lymphoma: R-chemotherapy vs. R-chemotherapy plus radiotherapy 53
Different IMRT solutions vs. 3D-Conformal Radiotherapy in early stage Hodgkin's lymphoma: dosimetric comparison and clinical considerations 53
Management of prostate cancer radiotherapy during the COVID-19 pandemic: A necessary paradigm change 53
Outcomes of Single Fraction Stereotactic Ablative Radiotherapy for Lung Metastases 52
A Strategy for Young Members within National Radiation Oncology Societies: the Italian Experience (AIRO Giovani Group) 51
Performance of an AI algorithm during the different phases of the COVID pandemics: what can we learn from the AI and vice versa 51
Brain metastases from lung cancer: Is MET an actionable target? 50
The Role of Native T1 and T2 Mapping Times in Identifying PD-L1 Expression and the Histological Subtype of NSCLCs 50
Radiotherapy treatment volumes for oligorecurrent nodal prostate cancer: a systematic review 49
THE EVOLVING ROLE OF RADIOTHERAPY IN EARLY STAGE HODGKIN’S LYMPHOMA 49
Radiotherapy in Pediatric Oncology 48
PACIFIC-R: First real-world study of patients with unresectable, stage III NSCLC treated with durvalumab after chemoradiotherapy 47
Extranodal Marginal Zone Lymphoma 46
Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy 46
Recent advancement on PD-L1 expression quantification: the radiologist perspective on CT-guided FNAC 45
Radiomics features as predictive and prognostic biomarkers in NSCLC 45
The 8th UICC/AJCC TNM edition for non-small cell lung cancer staging: getting off to a flying start? 45
Involved-Site Image-Guided Intensity Modulated Versus 3D Conformal Radiation Therapy in Early Stage Supradiaphragmatic Hodgkin Lymphoma 45
Treatment of metastatic melanoma: a multidisciplinary approach 45
Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy 44
Potential Benefit of Involved-Field Radiotherapy for Patients With Relapsed-Refractory Hodgkin's Lymphoma With Incomplete Response Before Autologous Stem Cell Transplantation 44
Available evidence on re-irradiation with stereotactic ablative radiotherapy following high-dose previous thoracic radiotherapy for lung malignancies 43
Total marrow and total lymphoid irradiation in bone marrow transplantation for acute leukaemia 43
Open issues in the therapeutic management of unresectable stage III NSCLC in the immunotherapy era 42
Is clinical radiosensitivity a complex genetically controlled event? 42
Large cohort observational study integrates current knowledge on changes in outcome for melanoma brain metastases in tyrosine kinase inhibitor (TKI)-immunotherapy era 42
Current role and future developments of radiotherapy in Hodgkin's lymphoma 42
A young boy with ventricular arrhythmias and thyroid dysgenesis: two genes are not enough? 41
Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease 41
A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer 39
Emo-linfopatie maligne 39
Plan optimization for mediastinal radiotherapy: Estimation of coronary arteries motion with ECG-gated cardiac imaging and creation of compensatory expansion margins 39
Stereotactic radiotherapy for early stage non-small cell lung cancer 38
Stereotactic Ablative Radiotherapy for stage I histologically proven non-small cell lung cancer: An Italian multicenter observational study 37
Radiation therapy for older patients with brain tumors 37
Stereotactic Ablative Radiation Therapy as First Local Therapy for Lung Oligometastases From Colorectal Cancer: A Single-Institution Cohort Study 36
Letter to the Editor regarding ESTRO-ASTRO guidelines on lung cancer radiotherapy during COVID-19 pandemic 36
New options and open issues in the management of unresectable stage III and in early-stage NSCLC: A report from an expert panel of Italian medical and radiation oncologists – INTERACTION group 35
No differences in radiological changes after 3D conformal vs VMAT-based stereotactic radiotherapy for early stage non-small cell lung cancer 35
Stereotactic Ablative Radiotherapy for Pulmonary Oligometastases and Oligometastatic Lung Cancer 35
The "BUONGIORNO" Project: Burnout Syndrome Among Young Italian Radiation Oncologists 34
Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab 34
Stereotactic body radiotherapy (SBRT) in combination with drugs in metastatic kidney cancer: a systematic review 34
Total Body Irradiation: Guidelines from the International Lymphoma Radiation Oncology Group (ILROG) 33
Review and Uses of Stereotactic Body Radiation Therapy for Oligometastases 33
Rationale and Design of a Single-Arm, Phase 2, Multi-Center Study of Chemo-Immunotherapy Followed by Hypo-Fractionated RT and Maintenance Immunotherapy in Patients With Unresectable Stage III NSCLC: The DEDALUS Trial 32
Peripheral blood complete remission after splenic irradiation in Mantle-Cell Lymphoma with 11q22-23 deletion and ATM inactivation 32
Role of radiotherapy in improving activity of immune-modulating drugs in advanced renal cancer: Biological rationale and clinical evidences 32
Stereotactic ablative radiation therapy prior to liver transplantation in hepatocellular carcinoma 32
Inclusion of heart substructures in the optimization process of volumetric modulated arc therapy techniques may reduce the risk of heart disease in Hodgkin's lymphoma patients 31
Multicenter Experience Using Total Lymphoid Irradiation and Antithymocyte Globulin as Conditioning for Allografting in Hematological Malignancies 31
New concepts and insights into the role of radiation therapy in extracranial metastatic disease 31
Prognostic role of pre-radiation therapy 18F-fluorodeoxyglucose positron emission tomography for primary mediastinal B-cell lymphomas treated with R-CHOP or R-CHOP-like chemotherapy plus radiation 31
Late toxicity in children undergoing hematopoietic stem cell transplantation with TBI-containing conditioning regimens for hematological malignancies 30
The STYRO 2011 project: a survey on perceived quality of training among young Italian radiation oncologists 30
Innovative technologies in thoracic radiation therapy for lung cancer 30
Post-ABVD/pre-radiotherapy (18)F-FDG-PET provides additional prognostic information for early-stage Hodgkin lymphoma: a retrospective analysis on 165 patients 30
Limited stage follicular lymphoma: Current role of radiation therapy 30
Stereotactic body radiation therapy for lung metastases 29
Interobserver variability of clinical target volume delineation in supra-diaphragmatic Hodgkin's disease: a multi-institutional experience 29
Radiotherapy and immune checkpoints inhibitors for advanced melanoma 28
Stereotactic body radiation therapy for early stage non-small cell lung cancer: Results of a prospective trial 28
Optimal Therapy for Early-Stage Hodgkin’s Lymphoma: Risk Adapting, Response Adapting, and Role of Radiotherapy 28
Management of patients with extensive small-cell lung cancer in the immunotherapy era: An Italian consensus through a Delphi approach 27
Interobserver variability in clinical target volume delineation for primary mediastinal B-cell lymphoma 27
Totale 4.903
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.601
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.601
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202156 0 0 0 0 0 2 6 11 4 1 1 31
2021/2022414 16 0 19 6 7 9 9 29 23 9 68 219
2022/20231.153 134 49 5 68 70 98 3 67 618 4 32 5
2023/2024617 59 67 71 37 73 193 56 12 0 23 1 25
2024/20251.337 43 121 34 47 19 60 46 53 367 73 124 350
2025/20261.473 217 228 273 309 372 74 0 0 0 0 0 0
Totale 5.234